| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| SHOULDER INNOVATIONS Aktie jetzt für 0€ handeln | |||||
| 10.09. | Shoulder Innovations erhält FDA-Zulassung für Titanimplantat und startet Markteinführung | 2 | Investing.com Deutsch | ||
| 10.09. | Shoulder Innovations receives FDA clearance for titanium implant | 1 | Investing.com | ||
| 10.09. | Shoulder Innovations Receives FDA 510(k) Clearance for N-22 Humeral Head and Initiates Full Commercial Launch | 147 | PR Newswire | Second Product Introduction on New Line of Technologies for Metal-Sensitive Patients
GRAND RAPIDS, Mich., Sept. 10, 2026 /PRNewswire/ -- Shoulder Innovations, Inc.... ► Artikel lesen | |
| 09.09. | Shoulder Innovations partners with ALM Ortho on implants | 3 | Investing.com | ||
| 12.08. | Shoulder Innovations auf Canaccord Genuity Konferenz: Wachstum beschleunigt, Margen steigen | 1 | Investing.com Deutsch | ||
| 10.08. | SHOULDER INNOVATIONS, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 10.08. | Shoulder Innovations Promotes Jon Osborne to Chief Commercial Officer | 205 | PR Newswire | GRAND RAPIDS, Mich., Aug. 10, 2026 /PRNewswire/ -- Shoulder Innovations, Inc. (Shoulder Innovations, or the company) (NYSE: SI), a commercial-stage medical technology... ► Artikel lesen | |
| 07.08. | Shoulder Innovations, Inc. GAAP EPS of -$0.49 misses by $0.03, revenue of $17.2M beats by $0.63M | 1 | Seeking Alpha | ||
| 07.08. | Shoulder Innovations projects $67M-$69M 2026 net revenue as InSet Neo targets FDA submission in H1 2027 | 1 | Seeking Alpha | ||
| 06.08. | Earnings Call: Shoulder Innovations steigert Umsatz um 56 % im 2. Quartal 2026 | 2 | Investing.com Deutsch | ||
| 06.08. | SHOULDER INNOVATIONS, INC. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 06.08. | Shoulder Innovations Reports Second Quarter 2026 Financial Results and Raises Full Year Outlook | 146 | PR Newswire | Generates First Half 2026 Revenue Growth of 60%
GRAND RAPIDS, Mich., Aug. 6, 2026 /PRNewswire/ -- Shoulder Innovations, Inc. (Shoulder Innovations, or the company)... ► Artikel lesen | |
| 29.07. | Biotech Stocks At 52-Week Highs - Incyte Rises With Q2 Results, Pulse Biosciences, Shoulder Innovations, Bioventus, LB Pharmaceuticals | 916 | AFX News | WASHINGTON (dpa-AFX) - The following biotech stocks reached a 52-week high on July 28, 2026, driven by key catalysts including positive quarterly results.Incyte Corporation (INCY)Incyte is a... ► Artikel lesen | |
| 29.06. | Shoulder Innovations closes $50M credit facility refinancing | 2 | Investing.com | ||
| 26.06. | SHOULDER INNOVATIONS, INC. - 8-K, Current Report | 2 | SEC Filings | ||
| 18.05. | Wall Street Analysts Think Shoulder Innovations, Inc. (SI) Could Surge 35.96%: Read This Before Placing a Bet | 2 | Zacks | ||
| 14.05. | Piper Sandler reiterates Overweight on Shoulder Innovations stock | 4 | Investing.com | ||
| 14.05. | Shoulder Innovations forecasts $65M-$68M 2026 net revenue as it raises guidance following Q1 growth | 1 | Seeking Alpha | ||
| 13.05. | SHOULDER INNOVATIONS, INC. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 13.05. | SHOULDER INNOVATIONS, INC. - 8-K, Current Report | 1 | SEC Filings |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| MEDLINE | 31,400 | +2,61 % | EQS-News: Medline EMEA: Medline startet die Kampagne "10 Minuten, die den Unterschied machen ", um den Wert der Zeit im Operationssaal hervorzuheben | EQS-News: Medline EMEA
/ Schlagwort(e): Sonstiges/Sonstiges
Medline startet die Kampagne "10 Minuten, die den Unterschied machen ", um den Wert der Zeit im Operationssaal hervorzuheben... ► Artikel lesen | |
| OMADA HEALTH | 18,200 | +0,55 % | Omada Health, Inc.: Omada Health Joins Lilly Employer Connect, Expanding Its Access Pathways for GLP-1 Care as Patients Seek More Lifestyle Support | SAN FRANCISCO, May 07, 2026 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA) announced it will serve as an independent program administrator in Eli Lilly and Company's Employer Connect program. Omada... ► Artikel lesen | |
| ADVANCED BIOMED | 7,040 | +4,61 % | Advanced Biomed Inc. - NT 10-K, Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 | ||
| MINIMED GROUP | 17,380 | -0,71 % | Medtronic plc: Medtronic Launches Exchange Offer to Complete Separation of MiniMed Group, Inc. | Medtronic shareholders can exchange their Medtronic ordinary shares for shares of MiniMedProvides Medtronic shareholders with option for a generally tax-free exchange... ► Artikel lesen | |
| CUPRINA HOLDINGS | 2,400 | -0,83 % | Cuprina Holdings (Cayman) LTD: Cuprina (Nasdaq: CUPR) to Acquire EBITDA-Positive Seven-Clinic Singapore Healthcare Group | Acquiring 100% of East Coast Podiatry (five clinics) and Orchard Clinic (two clinics) for approximately S$4.0 million (approximately US$3.1 million)Target Group generated FY2025 unaudited revenue... ► Artikel lesen | |
| CARLSMED | 12,500 | -1,57 % | Carlsmed Appoints Tony Jarc as Chief Product and AI Officer | CARLSBAD, Calif., Oct. 01, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) ("Carlsmed" or the "Company"), a medical technology company pioneering AI-enabled personalized spine surgery solutions... ► Artikel lesen | |
| PARK DENTAL PARTNERS | 18,000 | +9,09 % | Biotech Stocks At 52-Week Highs - Park Dental Partners +10%, Aveanna Healthcare +24%, Candel Therapeutics +10% on Q2 Reports, Labcorp Holdings, Hemab Therapeutics | LONDON (dpa-AFX) - The following biotech stocks reached 52-week highs on August 13, 2026, driven by key catalysts such as positive quarterly reports and the issuance of increased guidance figures.Park... ► Artikel lesen | |
| FRESENIUS | 43,635 | -0,38 % | Fresenius Kabi erhält Warnung von der US-Gesundheitsbehörde FDA | DJ Fresenius Kabi erhält Warnung von der US-Gesundheitsbehörde FDA
DOW JONES--Die Fresenius-Tochter Kabi hat einen Warnschuss von der US-Gesundheitsbehörde FDA erhalten. In dem am Dienstag veröffentlichten... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 37,860 | +0,66 % | JEFFERIES stuft Siemens Healthineers auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Siemens Healthineers mit einem Kursziel von 50 Euro auf "Buy" belassen. Accela sei ein Quantensprung in der Strahlentherapie... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 39,550 | -0,33 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 11,830 | 0,00 % | LifeStance Health Group, Inc.: LifeStance Reports Strong Second Quarter 2026 Financial Results and Raises Full Year Outlook | SCOTTSDALE, Ariz., Aug. 06, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 60,27 | +0,03 % | BMO Capital reiterates Outperform on BrightSpring Health stock | ||
| BILLIONTOONE | 105,90 | 0,00 % | BillionToOne Appoints Ethan Dmitrovsky, MD, as Chief Medical Officer, Oncology, to Lead Medical Strategy for Northstar | Renowned physician-scientist, former Director of Frederick National Laboratory, and one of the nation's most accomplished leaders in oncology joins BillionToOne... ► Artikel lesen | |
| HEARTFLOW | 49,270 | -0,10 % | AI Cardiac Diagnostics Pioneer Sets HeartFlow (HTFL) for High-Margin Expansion | ||
| PROCEPT BIOROBOTICS | 17,160 | 0,00 % | PROCEPT BioRobotics Corp - 8-K, Current Report |